Clinical Trial

Pregnancy Cohort Study: Pregnancy as a Window to Future Health

Study acronym: PregWin
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational cohort study is to gain deep insights into how metabolic disorders such as obesity or diabetes during pregnancy affect the metabolic and cardiovascular health of mother and child in the short and long term. It will investigate the following questions: * How do maternal metabolic disorders affect pregnancy outcomes? * How do maternal metabolic disorders affect fetal growth? * How do maternal metabolic disorders affect the newborn's metabolism and body composition? * How do maternal metabolic disorders during pregnancy affect breast milk composition? * How do maternal metabolic disorders during pregnancy affect the metabolic health of the mother after birth? Participants in this study are pregnant women who will be asked to come to the clinics for three visits during their pregnancy, as well as for the delivery of their baby, and one time 2-3 months thereafter. At each visit, researchers will perform physical examinations (such as body composition measurements) and collect biological samples (blood, urine, saliva), clinical information, and lifestyle data. At birth, researchers will collect cord blood and breast milk as well as clinical data of the delivery and the health of the baby. Researchers will measure body fat in newborn babies and at 2-3 months of age.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-04-07; most recent amendment 2026-04-09.
Trial Details
NCT Number NCT06925815
Lead Sponsor Medical University of Graz
Conditions Healthy Pregnant Women, Obese Pregnant Women, Gestational Diabetes
Enrollment 800 participants
Start Date 2023-07-27
Primary Completion 2033-06 (estimated)
Study Completion 2034-06 (estimated)
Updated on ClinicalTrials.gov 2026-04-13